Cystitis future or investigational therapies
Cystitis Microchapters | |
Diagnosis | |
Treatment | |
Case Studies | |
Cystitis future or investigational therapies On the Web | |
American Roentgen Ray Society Images of Cystitis future or investigational therapies | |
Risk calculators and risk factors for Cystitis future or investigational therapies | |
Overview
Cystitis can be hard to treat and recurrence can be an important concern. The complications of cystitis and some carcinomas associated with it sometimes require an aggressive approach. new modalities help improve the existing treatment options and limit further complications.Pulsed radio frequency treatment is one such advancement.[1]
Future Therapies
- Pulsed radiofrequency (PRF) treatment of the superior hypogastric plexus may replace conventional treatment invasive and on invasive modalities. It is responsible for providing superior hypogastric plexus with nondestructive modulation, so that majority of the pain signals are transferred from the pelvic viscera.[1]
- Hyperbaric Oxygen is used to treat hemorrhagic cystitis associated with exposure to radiation.[2] Hyperbaric Oxygen is also helpful in treating emphysematous cystitis as presence of gas in the bladder wall interferes with the tissue oxygenation and proper oxygenation may help to curtail the associated damage. [3]
References
- ↑ 1.0 1.1 Kim JH, Kim E, Kim BI (2016). "Pulsed radiofrequency treatment of the superior hypogastric plexus in an interstitial cystitis patient with chronic pain and symptoms refractory to oral and intravesical medications and bladder hydrodistension: A case report". Medicine (Baltimore). 95 (49): e5549. doi:10.1097/MD.0000000000005549. PMID 27930554.
- ↑ Chong V, Rice M (2016). "The effectiveness of hyperbaric oxygen therapy (HBOT) in radiation-induced haemorrhagic cystitis". N Z Med J. 129 (1446): 79–83. PMID 27906922.
- ↑ Garde H, Useros E, Hernando A, Chávez C, Paños E, Quijano P; et al. (2015). "[Emphysematous cystitis: Report of 2 cases with different outcomes]". Arch Esp Urol. 68 (7): 627–32. PMID 26331400.